|
|
Volumn 1, Issue 2, 2001, Pages 137-149
|
|
The design and synthesis of noncovalent factor Xa inhibitors.
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
1 (3 (AMINOMETHYL)PHENYL) N (3 FLUORO 2' (METHYLSULFONYL)(1,1' BIPHENYL) 4 YL) 3 (TRIFLUOROMETHYL) 1H PYRAZOLE 5 CARBOXAMIDE;
1-(3-(AMINOMETHYL)PHENYL)-N-(3-FLUORO-2'-(METHYLSULFONYL)(1,1'-BIPHENYL)-4-YL)-3-(TRIFLUOROMETHYL)-1H-PYRAZOLE-5-CARBOXAMIDE;
BLOOD CLOTTING FACTOR 10A;
FIBRINOLYTIC AGENT;
PYRAZOLE DERIVATIVE;
SULFONE;
ANIMAL;
BIOAVAILABILITY;
CHEMISTRY;
DOG;
DRUG ANTAGONISM;
DRUG DESIGN;
HALF LIFE TIME;
HUMAN;
IC 50;
PROTHROMBIN TIME;
RABBIT;
REVIEW;
SYNTHESIS;
ANIMALS;
BIOLOGICAL AVAILABILITY;
DOGS;
DRUG DESIGN;
FACTOR XA;
FIBRINOLYTIC AGENTS;
HALF-LIFE;
HUMANS;
INHIBITORY CONCENTRATION 50;
PROTHROMBIN TIME;
PYRAZOLES;
RABBITS;
SULFONES;
|
|
EID: 0035382790
PISSN: 15680266
EISSN: None
Source Type: Journal
DOI: 10.2174/1568026013395407 Document Type: Review |
|
Times cited : (42)
|
|
References (32)
|
